KUKJEON PHARMACEUTICAL Co.,Ltd Logo

KUKJEON PHARMACEUTICAL Co.,Ltd

A chemical solutions provider manufacturing Active Pharmaceutical Ingredients and electronic materials.

307750 | KO

Overview

Corporate Details

ISIN(s):
KR7307750000
LEI:
Country:
South Korea
Address:
경기도 안양시 동안구 학의로 282 B동 1516호 (관양동,금강펜테리움), 안양시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

KUKJEON PHARMACEUTICAL Co., Ltd. is a chemical total solution provider specializing in the manufacture and sale of Active Pharmaceutical Ingredients (APIs) and electronic materials. With approximately 50 years of operational experience, the company has established itself as an API specialist. Its primary business involves producing and supplying raw materials for specialized medicines, including choline alfoscerates, benfothiamines, spherical sorbents, and napamostat. In addition to its pharmaceutical operations, the company develops electronic materials. Kukjeon also offers services such as molecular design and technical support, aiming to provide a comprehensive range of chemical-based products and services to its customers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-16 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 12.2 KB
2025-09-04 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.8 KB
2025-08-27 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.7 KB
2025-08-19 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 134.5 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.3 MB
2025-08-06 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 132.7 KB
2025-07-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 133.1 KB
2025-07-07 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 135.0 KB
2025-06-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 143.5 KB
2025-06-16 00:00
Capital/Financing Update
전환사채(해외전환사채포함)발행후만기전사채취득
Korean 11.7 KB
2025-06-11 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 139.7 KB
2025-06-02 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 138.9 KB
2025-05-14 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.3 MB
2025-05-08 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 135.2 KB
2025-04-22 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 136.4 KB

Automate Your Workflow. Get a real-time feed of all KUKJEON PHARMACEUTICAL Co.,Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KUKJEON PHARMACEUTICAL Co.,Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KUKJEON PHARMACEUTICAL Co.,Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ArcticZymes Technologies Logo
Develops novel enzymes from Arctic organisms for diagnostics, therapeutics, and biopharma.
Norway
AZT
Arcturus Therapeutics Holdings Inc. Logo
Develops mRNA therapeutics and vaccines for rare respiratory, liver, and infectious diseases.
United States of America
ARCT
Arcus Biosciences, Inc. Logo
A clinical-stage biopharma developing small molecule and antibody combination therapies for cancer.
United States of America
RCUS
Arcutis Biotherapeutics, Inc. Logo
Develops and commercializes non-steroidal therapies for immune-mediated skin diseases.
United States of America
ARQT
ARDELYX, INC. Logo
Biopharma developing first-in-class drugs for cardiorenal and GI diseases like IBS-C and CKD.
United States of America
ARDX
ARECOR THERAPEUTICS PLC Logo
Biopharma firm enhancing drugs via reformulation for diabetes and pharmaceutical partners.
United Kingdom
AREC
argenx SE Logo
Develops first-in-class antibody therapies for severe autoimmune diseases.
Netherlands
1AE
Armata Pharmaceuticals, Inc. Logo
Developing bacteriophage therapeutics for antibiotic-resistant infections.
United States of America
ARMP
AroCell AB Logo
Develops and markets diagnostic tests for monitoring cancer and bacterial diseases.
Sweden
AROC
ArriVent BioPharma, Inc. Logo
A clinical-stage biopharma developing in-licensed oncology drugs for difficult-to-treat diseases.
United States of America
AVBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.